Intravaginal Sensor Feedback for Sacral Nerve Stimulation Placement

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for treating urinary and fecal incontinence, such as electrical stimulation therapy, face challenges in device positioning and identifying responsive individuals, particularly in women with pelvic floor disorders.

Innovation Solution

A system comprising an intravaginal device with sensors and an implantable lead for sacral nerve stimulation, combined with a medical device for electrical stimulation, allows for real-time monitoring of pelvic floor movements to optimize treatment efficacy and identify responsive subjects.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If electrical stimulation therapy is used to treat urinary and fecal incontinence, then treatment can be provided, but device positioning is difficult and identifying responsive individuals is challenging

Engineering Contradiction:
Improvetreatment effectivenessVSAvoiddevice positioning
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent employs sensors within the intravaginal device to detect pelvic floor muscle contractions and provides real-time feedback to both the patient and clinician. This feedback mechanism enables verification of proper device positioning and confirms effective nerve stimulation, thereby resolving the positioning difficulty and responsiveness identification challenges while maintaining treatment effectiveness.

Inventive Principle:
Principle #23Feedback

2Measurement precision

If multiple sensors are included in the intravaginal device, then measurement precision is improved, but device complexity increases

Engineering Contradiction:
Improvepelvic floor movement detectionVSAvoidsensor array configuration
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent divides the sensing function into multiple discrete sensors positioned at specific locations within the intravaginal device. Each sensor independently measures pelvic floor movement at its location, and the combined data provides comprehensive measurement precision. This segmentation approach achieves high measurement accuracy while keeping individual sensor components simple and manageable.

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS20260077200A1Devices, systems, and methods for treating urinary and fecal incontinence
Publication Date: 2026.03.19 AXENA HEALTH INC
  • US20260077200A1 patent drawing
  • US20260077200A1 patent drawing
  • US20260077200A1 patent drawing

AI summary

Featured are intravaginal devices and electrical stimulation devices, systems, thereof, and methods of using the devices and systems thereof to observe pelvic floor movements in order to diagnose, treat, or prevent urinary and fecal incontinence disorders (e.g., urge incontinence) and their accompanying symptoms or to diagnose and/or improve the efficacy of neuromodulation therapy.